Literature DB >> 9002327

Efficacy of standard glucose-based and reduced-osmolarity maltodextrin-based oral rehydration solutions: effect of sugar malabsorption.

M el-Mougi1, A Hendawi, H Koura, E Hegazi, O Fontaine, N F Pierce.   

Abstract

Previously we reported that standard oral rehydration salts (ORS) solution is not as effective as a reduced-osmolarity glucose-based ORS for the treatment of children with acute noncholera diarrhoea: with standard ORS the diarrhoea lasts longer, stool output is greater, serum sodium is higher, and there is more need for supplemental intravenous infusion. We studied a reduced-osmolarity maltodextrin (MD)-based ORS to determine whether it had similar benefits, and also the effect of sugar malabsorption on the efficacy of standard and MD-based ORS. A total of 90 boys aged 3-24 months with acute noncholera diarrhoea and moderate dehydration were randomly assigned to either standard ORS (glucose 20 g/l, osmolarity 311 mmol/l) or MD-ORS (MD 50 g/l, osmolarity 227 mmol/l). There were no differences in treatment results. Some 46% of subjects had a high total stool output (> 300 g/kg), which was unrelated to the type of ORS given. High stool output was significantly associated with a longer duration of diarrhoea (33 vs. 15 hours; P < 0.001), a persistently elevated serum sodium (149 vs. 144 mmol/l at 24 h; P < 0.02), the need for intravenous infusion (11/41 vs. 0/48; P < 0.002), and an increase in faecal reducing substances (10.8 vs. 3.4 g/l at 24 h; P < 0.001). We conclude that some children given standard ORS develop osmotic diarrhoea owing to the combined effect of transient sugar malabsorption and slight hypertonicity of the ORS. Earlier studies show that this adverse outcome can largely be avoided when extra water is given in reduced-osmolarity glucose-based ORS. Reduced osmolarity has no benefit, however, when glucose is replaced by maltodextrin, probably because the sugars released by hydrolysis of MD, when malabsorbed, raise the intraluminal osmolarity to equal or exceed that of standard ORS. Thus, reduced-osmolarity glucose-based ORS is superior to both standard ORS and reduced-osmolarity solutions based on maltodextrin and probably other complex carbohydrates. Studies are in progress to define the optimal formulation of reduced-osmolarity glucose-based ORS.

Entities:  

Keywords:  Africa; Age Factors; Arab Countries; Biology; Carbohydrate Metabolic Effects; Carbohydrates; Child; Comparative Studies; Demographic Factors; Developing Countries; Diarrhea; Diarrhea, Infantile--prevention and control; Diseases; Egypt; Electrolyte Balance; Glucose Metabolism Effects; Homeostasis; Ingredients And Chemicals; Mediterranean Countries; Metabolic Effects; Northern Africa; Oral Rehydration; Physiology; Population; Population Characteristics; Research Methodology; Research Report; Studies; Treatment; Youth

Mesh:

Substances:

Year:  1996        PMID: 9002327      PMCID: PMC2486870     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  13 in total

1.  A WARD TEST FOR SUGAR IN FAECES.

Authors:  K R KERRY; C M ANDERSON
Journal:  Lancet       Date:  1964-05-02       Impact factor: 79.321

Review 2.  Oral therapy for acute diarrhea. The underused simple solution.

Authors:  M E Avery; J D Snyder
Journal:  N Engl J Med       Date:  1990-09-27       Impact factor: 91.245

Review 3.  High sugar worse than high sodium in oral rehydration solutions.

Authors:  G W Meeuwisse
Journal:  Acta Paediatr Scand       Date:  1983-03

4.  Rice-based oral rehydration solution decreases the stool volume in acute diarrhoea.

Authors:  A M Molla; S M Ahmed; W B Greenough
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Oral solutions for gastroenteritis--optimal glucose concentration.

Authors:  B Kjellman; E Ronge
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

6.  Oral rehydration in acute infantile diarrhoea with a glucose-polymer electrolyte solution.

Authors:  B K Sandhu; B J Jones; C G Brook; D B Silk
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

7.  Transient monosaccharide intolerance in infants with acute and protracted diarrhoea.

Authors:  P D Manuel; D J Mukhtar; J A Walker-Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984       Impact factor: 2.839

8.  Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.

Authors:  S M Gore; O Fontaine; N F Pierce
Journal:  BMJ       Date:  1992-02-01

9.  Clinical experience with a hypotonic oral rehydration solution in acute diarrhoea.

Authors:  T Rautanen; S el-Radhi; T Vesikari
Journal:  Acta Paediatr       Date:  1993-01       Impact factor: 2.299

Review 10.  The treatment of acute diarrhea in children. An historical and physiological perspective.

Authors:  N Hirschhorn
Journal:  Am J Clin Nutr       Date:  1980-03       Impact factor: 7.045

View more
  5 in total

Review 1.  The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality.

Authors:  Melinda K Munos; Christa L Fischer Walker; Robert E Black
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

Review 2.  Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review.

Authors:  S Hahn; Y Kim; P Garner
Journal:  BMJ       Date:  2001-07-14

Review 3.  Nutrition, Health, and Regulatory Aspects of Digestible Maltodextrins.

Authors:  Denise L Hofman; Vincent J van Buul; Fred J P H Brouns
Journal:  Crit Rev Food Sci Nutr       Date:  2016-09-09       Impact factor: 11.176

Review 4.  Polymer-based oral rehydration solution for treating acute watery diarrhoea.

Authors:  Germana V Gregorio; Maria Liza M Gonzales; Leonila F Dans; Elizabeth G Martinez
Journal:  Cochrane Database Syst Rev       Date:  2016-12-13

Review 5.  Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT).

Authors:  David Nalin
Journal:  Trop Med Infect Dis       Date:  2021-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.